Literature DB >> 10481096

Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface.

R Matatov1, J Goldhar, E Skutelsky, I Sechter, R Perry, R Podschun, H Sahly, K Thankavel, S N Abraham, I Ofek.   

Abstract

We screened phase variants of Klebsiella pneumoniae isolates for the expression of capsule and type 1 fimbriae and found that all of the 22 blood isolates were encapsulated and did not express type 1 fimbriae while 10 of 11 urinary tract isolates expressed type 1 fimbriae but were unencapsulated. Phase variants from selected isolates were found to be either unencapsulated and fimbriated or lacked both structures. Variants expressing both structures were not detected. Fimbrial subunits FimH and FimA were localized in the periplasmic space of the parent strain and on the surface of the unencapsulated variants. The results suggest that capsule formation impedes assembly of pre-formed fimbrial subunits on the bacterial surface.

Entities:  

Mesh:

Year:  1999        PMID: 10481096     DOI: 10.1111/j.1574-6968.1999.tb08717.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

2.  Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D.

Authors:  Elena Kostina; Itzhak Ofek; Erika Crouch; Rotem Friedman; Lea Sirota; Gil Klinger; Hany Sahly; Yona Keisari
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Capsule and fimbria interaction in Klebsiella pneumoniae.

Authors:  Mark A Schembri; Jens Blom; Karen A Krogfelt; Per Klemm
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Manno(rhamno)biose-containing capsular polysaccharides of Klebsiella pneumoniae enhance opsono-stimulation of human polymorphonuclear leukocytes.

Authors:  Hany Sahly; Yona Keisari; Itzhak Ofek
Journal:  J Innate Immun       Date:  2008-09-09       Impact factor: 7.349

5.  Lipid-based signaling modulates DNA repair response and survival against Klebsiella pneumoniae infection in host cells and in mice.

Authors:  Huang Huang; Andrew Weaver; Erxi Wu; Yi Li; Hongwei Gao; Weimin Fan; Min Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

6.  Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae.

Authors:  I Ofek; A Mesika; M Kalina; Y Keisari; R Podschun; H Sahly; D Chang; D McGregor; E Crouch
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae.

Authors:  H Sahly; R Podschun; T A Oelschlaeger; M Greiwe; H Parolis; D Hasty; J Kekow; U Ullmann; I Ofek; S Sela
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.

Authors:  David A Rosen; Jerome S Pinkner; Jennifer N Walker; Jennifer Stine Elam; Jennifer M Jones; Scott J Hultgren
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

9.  Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression.

Authors:  David A Rosen; Jerome S Pinkner; Jennifer M Jones; Jennifer N Walker; Steven Clegg; Scott J Hultgren
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

10.  Klebsiella pneumoniae FimK Promotes Virulence in Murine Pneumonia.

Authors:  David A Rosen; Julia K Hilliard; Kristin M Tiemann; Elizabeth M Todd; S Celeste Morley; David A Hunstad
Journal:  J Infect Dis       Date:  2015-09-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.